Table 4. Genotypic distribution among cases and controls.

Counts represent number of individuals.

Chr	rsID	Gene	A1 (minor)	A2 (major)	Total	Not Constant-severe Pain				Constant-severe Pain
						A1/A1	A1/A2	A2/A2	Control	A1/A1	A1/A2	A2/A2	Cases
2	rs141909432	NBAS	A	G	1355	0	9	560	569	0	33	753	786
2	rs2968817	RTN4	A	G	1356	47	274	248	569	59	303	425	787
3	rs113388258	CAND2,TMEM40	C	T	1357	0	51	519	570	4	100	683	787
3	rs4624600	ROBO2	C	T	1347	72	193	300	565	155	287	340	782
5	rs59442633	CTNND2	C	T	1355	1	74	495	570	11	123	651	785
5	rs458909	PPP2R2B	A	C	1357	0	10	560	570	0	36	751	787
8	rs11300774	SGCZ	T	TA	1356	43	301	225	569	46	478	263	787
11	rs2123323	CNTN5	T	C	1356	97	300	173	570	182	392	212	786
11	rs36106152	CNTN5	G	GA	1357	65	231	274	570	82	381	324	787
12	rs71450224	KSR2	A	AAAAG	1354	41	234	295	570	45	303	436	784
17	rs12449867	BAIAP2-AS1	C	T	1355	49	239	281	569	99	376	311	786
17	rs9898347	BAIAP2	A	G	1356	72	296	202	570	91	340	355	786
17	rs34176221	BAIAP2	AT	A	1354	88	284	197	569	177	391	217	785
18	rs1619323	DCC	C	T	1355	31	195	343	569	36	260	490	786
22	rs8137390	PHF21B	G	A	1356	20	177	372	569	35	262	490	787